The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Oral drug delivery is the most preferred administration route due to noninvasive, high patient compliance, convenient to handle, and does not require any specific sterile conditions. However, some of the drugs administered orally face several physical, biological, and biochemical barriers which lower the therapeutic efficacy of the drugs before getting absorbed into the systemic circulation. The utilization of nanocarriers for oral drug delivery overcome abovementioned barriers and considered as an alternative strategy to address the drawbacks of oral drug delivery. In this chapter, the recent advancement of nanocarriers in oral drug delivery application for the treatment of various diseases is summarized. Furthermore, the chapter explains how different nanocarriers designing technology enhance the therapeutic potential to overcome the various barriers such as physical, biological, and biochemical.
Although, in recent years, several nanocarrier-based drug delivery technologies have been evolved and showing promising results but still it is far from the real utilization in the clinic.
The global Oral Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Oral Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Drug Delivery.
Report Scope
The Oral Drug Delivery market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Drug Delivery manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company(Partial List)
- AstraZeneca Plc.
- Mylan N.V.
- Sanofi
- F. Hoffman-La-Roche Ltd.
- Bristol-Myers Squibb Company
- Sun Pharmaceuticals Industries Ltd
- Abbott Laboratories
- Merck & Co. Inc.
- Novartis AG
- Pfizer Inc.
- Vectura Group plc.
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc
Segment by Type
- Diffusion Controlled Release System
- Dissolution Controlled Release System
- Ion Exchange Resins Controlled Release
- Hydro-dynamically Balanced Drug Delivery System
- Osmotically Controlled Release System
- Dissolution & Diffusion Controlled Release System
Segment by Application
- Hospitals
- Clinics
- Other
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Oral Drug Delivery Market Overview
1.1 Product Overview and Scope of Oral Drug Delivery
1.2 Oral Drug Delivery Segment by Type
1.2.1 Global Oral Drug Delivery Market Value Comparison by Type (2024-2030)
1.2.2 Diffusion Controlled Release System
1.2.3 Dissolution Controlled Release System
1.2.4 Ion Exchange Resins Controlled Release
1.2.5 Hydro-dynamically Balanced Drug Delivery System
1.2.6 Osmotically Controlled Release System
1.2.7 Dissolution & Diffusion Controlled Release System
1.3 Oral Drug Delivery Segment by Application
1.3.1 Global Oral Drug Delivery Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Oral Drug Delivery Market Size Estimates and Forecasts
1.4.1 Global Oral Drug Delivery Revenue 2019-2030
1.4.2 Global Oral Drug Delivery Sales 2019-2030
1.4.3 Global Oral Drug Delivery Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Drug Delivery Market Competition by Manufacturers
2.1 Global Oral Drug Delivery Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Drug Delivery Average Price by Manufacturers (2019-2024)
2.4 Global Oral Drug Delivery Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Drug Delivery, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Drug Delivery, Product Type & Application
2.7 Oral Drug Delivery Market Competitive Situation and Trends
2.7.1 Oral Drug Delivery Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Drug Delivery Players Market Share by Revenue
2.7.3 Global Oral Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Drug Delivery Retrospective Market Scenario by Region
3.1 Global Oral Drug Delivery Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Drug Delivery Global Oral Drug Delivery Sales by Region: 2019-2030
3.2.1 Global Oral Drug Delivery Sales by Region: 2019-2024
3.2.2 Global Oral Drug Delivery Sales by Region: 2025-2030
3.3 Global Oral Drug Delivery Global Oral Drug Delivery Revenue by Region: 2019-2030
3.3.1 Global Oral Drug Delivery Revenue by Region: 2019-2024
3.3.2 Global Oral Drug Delivery Revenue by Region: 2025-2030
3.4 North America Oral Drug Delivery Market Facts & Figures by Country
3.4.1 North America Oral Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Drug Delivery Sales by Country (2019-2030)
3.4.3 North America Oral Drug Delivery Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Drug Delivery Market Facts & Figures by Country
3.5.1 Europe Oral Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Drug Delivery Sales by Country (2019-2030)
3.5.3 Europe Oral Drug Delivery Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Drug Delivery Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Drug Delivery Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Drug Delivery Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Drug Delivery Market Facts & Figures by Country
3.7.1 Latin America Oral Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Drug Delivery Sales by Country (2019-2030)
3.7.3 Latin America Oral Drug Delivery Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Drug Delivery Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Drug Delivery Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Drug Delivery Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Drug Delivery Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Drug Delivery Sales by Type (2019-2030)
4.1.1 Global Oral Drug Delivery Sales by Type (2019-2024)
4.1.2 Global Oral Drug Delivery Sales by Type (2025-2030)
4.1.3 Global Oral Drug Delivery Sales Market Share by Type (2019-2030)
4.2 Global Oral Drug Delivery Revenue by Type (2019-2030)
4.2.1 Global Oral Drug Delivery Revenue by Type (2019-2024)
4.2.2 Global Oral Drug Delivery Revenue by Type (2025-2030)
4.2.3 Global Oral Drug Delivery Revenue Market Share by Type (2019-2030)
4.3 Global Oral Drug Delivery Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Drug Delivery Sales by Application (2019-2030)
5.1.1 Global Oral Drug Delivery Sales by Application (2019-2024)
5.1.2 Global Oral Drug Delivery Sales by Application (2025-2030)
5.1.3 Global Oral Drug Delivery Sales Market Share by Application (2019-2030)
5.2 Global Oral Drug Delivery Revenue by Application (2019-2030)
5.2.1 Global Oral Drug Delivery Revenue by Application (2019-2024)
5.2.2 Global Oral Drug Delivery Revenue by Application (2025-2030)
5.2.3 Global Oral Drug Delivery Revenue Market Share by Application (2019-2030)
5.3 Global Oral Drug Delivery Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca Plc.
6.1.1 AstraZeneca Plc. Corporation Information
6.1.2 AstraZeneca Plc. Description and Business Overview
6.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Plc. Oral Drug Delivery Product Portfolio
6.1.5 AstraZeneca Plc. Recent Developments/Updates
6.2 Mylan N.V.
6.2.1 Mylan N.V. Corporation Information
6.2.2 Mylan N.V. Description and Business Overview
6.2.3 Mylan N.V. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan N.V. Oral Drug Delivery Product Portfolio
6.2.5 Mylan N.V. Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Drug Delivery Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 F. Hoffman-La-Roche Ltd.
6.4.1 F. Hoffman-La-Roche Ltd. Corporation Information
6.4.2 F. Hoffman-La-Roche Ltd. Description and Business Overview
6.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Portfolio
6.4.5 F. Hoffman-La-Roche Ltd. Recent Developments/Updates
6.5 Bristol-Myers Squibb Company
6.5.1 Bristol-Myers Squibb Company Corporation Information
6.5.2 Bristol-Myers Squibb Company Description and Business Overview
6.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bristol-Myers Squibb Company Oral Drug Delivery Product Portfolio
6.5.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.6 Sun Pharmaceuticals Industries Ltd
6.6.1 Sun Pharmaceuticals Industries Ltd Corporation Information
6.6.2 Sun Pharmaceuticals Industries Ltd Description and Business Overview
6.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Portfolio
6.6.5 Sun Pharmaceuticals Industries Ltd Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Oral Drug Delivery Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Merck & Co. Inc.
6.8.1 Merck & Co. Inc. Corporation Information
6.8.2 Merck & Co. Inc. Description and Business Overview
6.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck & Co. Inc. Oral Drug Delivery Product Portfolio
6.8.5 Merck & Co. Inc. Recent Developments/Updates
6.9 Novartis AG
6.9.1 Novartis AG Corporation Information
6.9.2 Novartis AG Description and Business Overview
6.9.3 Novartis AG Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novartis AG Oral Drug Delivery Product Portfolio
6.9.5 Novartis AG Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Corporation Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Inc. Oral Drug Delivery Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
6.11 Vectura Group plc.
6.11.1 Vectura Group plc. Corporation Information
6.11.2 Vectura Group plc. Oral Drug Delivery Description and Business Overview
6.11.3 Vectura Group plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Vectura Group plc. Oral Drug Delivery Product Portfolio
6.11.5 Vectura Group plc. Recent Developments/Updates
6.12 GlaxoSmithKline plc.
6.12.1 GlaxoSmithKline plc. Corporation Information
6.12.2 GlaxoSmithKline plc. Oral Drug Delivery Description and Business Overview
6.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.12.4 GlaxoSmithKline plc. Oral Drug Delivery Product Portfolio
6.12.5 GlaxoSmithKline plc. Recent Developments/Updates
6.13 Johnson & Johnson Services, Inc
6.13.1 Johnson & Johnson Services, Inc Corporation Information
6.13.2 Johnson & Johnson Services, Inc Oral Drug Delivery Description and Business Overview
6.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Johnson & Johnson Services, Inc Oral Drug Delivery Product Portfolio
6.13.5 Johnson & Johnson Services, Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Drug Delivery Industry Chain Analysis
7.2 Oral Drug Delivery Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Drug Delivery Production Mode & Process
7.4 Oral Drug Delivery Sales and Marketing
7.4.1 Oral Drug Delivery Sales Channels
7.4.2 Oral Drug Delivery Distributors
7.5 Oral Drug Delivery Customers
8 Oral Drug Delivery Market Dynamics
8.1 Oral Drug Delivery Industry Trends
8.2 Oral Drug Delivery Market Drivers
8.3 Oral Drug Delivery Market Challenges
8.4 Oral Drug Delivery Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
